Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.95B
Enterprise Value4.77B
P/E Ratio-10.41
PEG Ratio0.13
Price/Sales Ratio10.6
Price/Book Ratio0.54
Enterprise/Revenue10.03
Enterprise/EBITDA-14.8

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.72
Operating Margin-0.9
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.1

Income Statement

Revenue274.81M
Revenue/Share1.12
Gross Profit145.21M
EBITDA-135.93M
Net Income-116.28M
Diluted EPS-0.18

Balance Sheet

Total Cash208.57M
Total Cash/Share0.91
Total Debt61.93M
Total Debt/Equity0.04
Current Ratio3.78
Book Value Per Share8.01

Price History

52-Week Change-50
52-Week High9.17
52-Week Low3.04
Moving Average 50 Days4.9
Moving Average 200 Days5.47

Statistics

Average Volume8.79M
Shares Outstanding659.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor2:1
Last Split DateJuly 10, 2015
AD